155 related articles for article (PubMed ID: 37773579)
1. Pan-immune-inflammation value as a prognostic tool for overall survival and disease-free survival in non-metastatic muscle-invasive bladder cancer.
Kayar R; Bastug Y; Tokuc E; Topaktas R; Akyurek EA; Kayar K; Artuk I; Ozturk M
Int Urol Nephrol; 2024 Feb; 56(2):509-518. PubMed ID: 37773579
[TBL] [Abstract][Full Text] [Related]
2. Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy.
Russo P; Palermo G; Iacovelli R; Ragonese M; Ciccarese C; Maioriello G; Fantasia F; Bizzarri FP; Marino F; Moosavi K; Nigro D; Filomena GB; Gavi F; Rossi F; Pinto F; Racioppi M; Foschi N
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339402
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent 177Lu-PSMA-617.
Şahin E; Kefeli U; Zorlu Ş; Seyyar M; Ozkorkmaz Akdag M; Can Sanci P; Karakayali A; Ucuncu Kefeli A; Bakkal Temi Y; Cabuk D; Uygun K
Medicine (Baltimore); 2023 Nov; 102(47):e35843. PubMed ID: 38013293
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
Gorgel SN; Akin Y; Koc EM; Kose O; Ozcan S; Yilmaz Y
Int Urol Nephrol; 2020 Mar; 52(3):469-473. PubMed ID: 31659597
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy.
Lei Y; Jiao D; Yao Z; Wang L; Zhao Z
Arch Esp Urol; 2022 Apr; 75(3):287-294. PubMed ID: 35435163
[TBL] [Abstract][Full Text] [Related]
6. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy.
Wang R; Yan Y; Liu S; Yao X
Biomed Res Int; 2019; 2019():3628384. PubMed ID: 31662975
[TBL] [Abstract][Full Text] [Related]
8. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
Zhang J; Zhou X; Ding H; Wang L; Liu S; Liu Y; Chen Z
BMC Urol; 2020 Mar; 20(1):31. PubMed ID: 32192483
[TBL] [Abstract][Full Text] [Related]
10. A decreased preoperative platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value are associated with the poorer survival of patients with a stent inserted as a bridge to curative surgery for obstructive colorectal cancer.
Sato R; Oikawa M; Kakita T; Okada T; Abe T; Tsuchiya H; Akazawa N; Ohira T; Harada Y; Okano H; Ito K; Tsuchiya T
Surg Today; 2023 Apr; 53(4):409-419. PubMed ID: 35987967
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection.
Wang SB; Chen JY; Xu C; Cao WG; Cai R; Cao L; Cai G
Front Oncol; 2022; 12():1040495. PubMed ID: 36387250
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
14. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
15. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.
Zhang GM; Zhu Y; Luo L; Wan FN; Zhu YP; Sun LJ; Ye DW
Tumour Biol; 2015 Nov; 36(11):8537-43. PubMed ID: 26032095
[TBL] [Abstract][Full Text] [Related]
16. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy.
Şahin AB; Cubukcu E; Ocak B; Deligonul A; Oyucu Orhan S; Tolunay S; Gokgoz MS; Cetintas S; Yarbas G; Senol K; Goktug MR; Yanasma ZB; Hasanzade U; Evrensel T
Sci Rep; 2021 Jul; 11(1):14662. PubMed ID: 34282214
[TBL] [Abstract][Full Text] [Related]
17. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
[TBL] [Abstract][Full Text] [Related]
18. The preoperative pan-immune-inflammation value is a novel prognostic predictor for with stage I-III colorectal cancer patients undergoing surgery.
Sato S; Shimizu T; Ishizuka M; Suda K; Shibuya N; Hachiya H; Iso Y; Takagi K; Aoki T; Kubota K
Surg Today; 2022 Aug; 52(8):1160-1169. PubMed ID: 35015151
[TBL] [Abstract][Full Text] [Related]
19. The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors.
Corti F; Lonardi S; Intini R; Salati M; Fenocchio E; Belli C; Borelli B; Brambilla M; Prete AA; Quarà V; Antista M; Fassan M; Morano F; Spallanzani A; Ambrosini M; Curigliano G; de Braud F; Zagonel V; Fucà G; Pietrantonio F
Eur J Cancer; 2021 Jun; 150():155-167. PubMed ID: 33901794
[TBL] [Abstract][Full Text] [Related]
20. The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor.
Chen X; Hong X; Chen G; Xue J; Huang J; Wang F; Ali WADS; Li J; Zhang L
Transl Oncol; 2022 Mar; 17():101338. PubMed ID: 34999541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
